Why Is Otezla So Hard to Find? [Explained for 2026]

If your doctor just prescribed Otezla (apremilast) and you're struggling to get your hands on it, you're not alone. Patients with plaque psoriasis, psoriatic arthritis, and Behçet's disease regularly find that filling an Otezla prescription is nothing like picking up a blood pressure medication or antibiotic. There's no shortage of Otezla in the traditional sense — the drug is manufactured and supplied consistently. But the path to actually getting it in your hands involves a series of hurdles that catch many patients off guard.

Otezla Is Only Available at Specialty Pharmacies

The single biggest reason Otezla is hard to find is that it is not stocked at regular retail pharmacies. You cannot walk into your neighborhood CVS, Walgreens, Rite Aid, or grocery store pharmacy and pick it up. Otezla is classified as a specialty medication, meaning it can only be dispensed through a network of specialty pharmacies that are part of Amgen's distribution program.

Specialty pharmacies are not the same as retail pharmacies. They are designed to handle complex, high-cost medications that require special handling, patient counseling, and insurance coordination. Examples include CVS Specialty, Accredo, Optum Rx, and Walgreens Specialty — but these are separate operations from their standard retail counterparts. Your insurance plan may also restrict you to specific specialty pharmacies in their network, which adds another layer of complexity.

The specialty pharmacy model exists for several reasons: to ensure patients receive education about proper use and potential side effects, to coordinate closely with insurance companies, and to manage the very high cost of the medication. But from the patient's perspective, it means your prescription won't simply be ready the next day at a location near you.

Prior Authorization: The Biggest Bottleneck

Even after your doctor has determined that Otezla is the right treatment for you, your insurance company may not agree right away. Most commercial insurance plans, Medicare Part D plans, and Medicaid programs require prior authorization (PA) before they will cover Otezla. This means your insurer needs to review your medical records, diagnoses, and treatment history before approving the prescription.

Prior authorization processing for Otezla commonly takes 1 to 4 weeks. During this waiting period, you are essentially unable to fill your prescription — even if you are experiencing significant symptoms. This delay is one of the most frustrating aspects of the Otezla access process. The good news is that Amgen offers a Bridge to Commercial Coverage program that provides free Otezla for up to 12 prescription fills while your PA is pending (more on that below).

Step Therapy: Why Insurers May Require You to Try Other Drugs First

Many insurance plans impose step therapy (also called "fail first" requirements) for Otezla. This means your insurer requires documentation that you have already tried and failed — or have a contraindication to — cheaper medications before they will approve coverage for Otezla. Common step therapy requirements include trials of methotrexate, cyclosporine, acitretin, or other conventional DMARDs (disease-modifying antirheumatic drugs).

For some patients, this is a manageable step — they may already have tried these medications. But for newly diagnosed patients or those whose doctors believe Otezla is the best first-line option, step therapy can mean months of delays and additional treatment trials before getting access to the medication their provider actually recommended. Your dermatologist or rheumatologist can help build the case with detailed clinical documentation to either satisfy step therapy requirements or appeal them.

The Cost Factor: Why Price Creates an Access Barrier

Otezla carries a list price of approximately $5,000 to $6,800 per month — roughly $60,000 to $81,600 per year for a 30-day supply. This makes it one of the more expensive oral medications for psoriatic disease. Unlike methotrexate, which costs under $30 per month in generic form, Otezla does not have a US generic available. A court ruling in April 2023 confirmed Amgen's patents on Otezla until approximately 2028, meaning affordable generic versions won't reach the US market until at least 2028-2029.

Insurance typically places Otezla on a specialty tier (Tier 4 or 5), which comes with the highest out-of-pocket costs. Even with insurance, copays can be substantial unless you qualify for Amgen's copay assistance programs. Patients who are uninsured face the full retail cost, making the medication effectively inaccessible without financial assistance.

What You Can Do If You're Having Trouble Getting Otezla

Despite these hurdles, most patients do eventually get access to Otezla. Here are the most effective steps to take:

Enroll in Amgen SupportPlus: Call 1-833-442-6436 or visit otezla.com/enroll. This program connects you with insurance support, the Bridge program, and copay assistance.

Use the Bridge to Commercial Coverage program: If you have commercial insurance and your PA is delayed, you may qualify to receive free Otezla for up to 12 fills while waiting for approval.

Ask your doctor's office to submit a detailed PA letter: A well-documented prior authorization request with your diagnosis history, prior treatment trials, and clinical rationale speeds up the approval process significantly.

Confirm your insurance's specialty pharmacy network: Your plan may require you to use a specific specialty pharmacy. Using an out-of-network pharmacy may result in denial of coverage.

If uninsured, apply to the Amgen Safety Net Foundation: Low-income uninsured or underinsured patients may qualify for free medication through Amgen's patient assistance program.

How medfinder Can Help You Navigate the Process

Finding Otezla involves coordinating between your doctor's office, insurance company, and specialty pharmacy — and it can feel like a full-time job. medfinder is a service that helps patients locate where their specific medication is available. You provide your medication, dosage, and location, and medfinder contacts pharmacies on your behalf to find out which ones can fill your prescription — then texts you the results.

If you're navigating the specialty pharmacy maze, read our companion guide: How to Find Otezla in Stock Near You (Tools + Tips). You can also learn about your financial options in our guide to How to Save Money on Otezla in 2026.

The Bottom Line

Otezla is not in shortage — the supply chain is stable and the drug is manufactured reliably. What makes it hard to access is a combination of structural factors: it's a specialty-only medication, requires prior authorization from most insurers, is subject to step therapy requirements at many plans, and carries a very high list price with no generic alternative in the US. For most patients, the path forward involves working closely with your prescriber, enrolling in Amgen SupportPlus, and using available financial assistance programs. With the right support, the vast majority of patients who qualify for Otezla can ultimately get it.